Clinical analysis of Chinese infertility women with premature ovarian failure

Neuroendocrinology Letters

Volumn 28, Issue 5, 2007, Pages 580-584

  Zhang, Peng ^a,b   Shi, Yuhua ^a   Gao, Xunan ^a   Wang, Shan ^a   Wang, Junchao ^a   Chen, Zi Jiang ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Qingdao Women and Children Health Care Centers   (China)

Author keywords

Clinical analysis; Estrogen; Infertility; Karyotype; Premature ovarian failure

Indexed keywords

CORTICOSTEROID; ESTROGEN; FOLLITROPIN; PROGESTERONE;

ADD ON THERAPY; ARTICLE; AUTOIMMUNE DISEASE; CHINESE; CHROMOSOME ABERRATION; CLINICAL EVALUATION; CLINICAL FEATURE; DONOR; DRUG DOSAGE FORM COMPARISON; ENDOCRINE FUNCTION; FEMALE; FEMALE INFERTILITY; GENERAL CONDITION IMPROVEMENT; GENETIC SCREENING; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; KARYOTYPE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OOCYTE DONOR; PATHOGENESIS; PREMATURE OVARIAN FAILURE; REPRODUCTION;

EID: 38049079681     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS. (1996). Characterization of idiopathic premature ovarian failure. Fertil Steril. 65(2): 337-41.
2. Coulam CB, Adamson SC, Annegers JF. (1986). Incidence of premature ovarian failure. Obstet and gynecol. 67: 604-655.
3. Fatemi HM, Bourgain C, Donoso P et al. (2007). Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. Hum Reprod. 22(5): 1260-3.
4. Gandar R. Premature failure of the ovaries. (1988). J Gynecol Obstet Biol Reprod (Paris). 17(3): 351-61.
5. Kalantaridou SN, Davis SR, Nelson L M. (1998). Premature ovarian failure. Endocrinol Metab Clin North Am. 27(4): 989-1006.
6. Kelkar RL, Meherji PK, Kadam et al. (2005). Circulating auto-antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure. J Reprod Immunol. 66(1): 53-67.
7. Letur H, Martin-Pont B, Fenichel P et al. (2004). Spontaneous pregnancies and premature menopause. Gynecol Obstet Fertil. 32(9): 748-55.
8. Nelson LM, Covington SN, Rebar RW. (2005). An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril. 83(5): 1327-32.
9. Pires ES, Parte PP, Meherji PK et al. (2006). Naturally occurring anti-albumin antibodies are responsible for false positivity in diagnosis of autoimmune premature ovarian failure. J Histochem Cytochem. 54(4):397-405.
10. Portnoi MF, Aboura A, Tachdjian G et al. (2006). Molecular cytogenetic studies of Xq critical regions in premature ovarian failure patients. Hum Reprod. 21(9): 329-34.
11. Tartagni M, Cicinelli E, De Pergola G, De Salvia MA, Lavopa C, Loverro G. (2007). Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril. 87(4): 858-61.
12. van Kasteren YM, Schoemaker J. (1999). Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update. 5(5): 483-92.
13. Woad KJ, Watkins WJ, Predergast D, Shelling AN. (2006). The genetic basis of premature ovarian failure. Aust N Z J Obstet Gynaecol. 46(3): 242-4.
14. Zargar AH, Salahuddin M, Wani AI et al. (2000). Pregnancy in premature ovarian failure: a possible role of estrogen plus progesterone treatment. J Assoc Physicians India. 48(2): 213-5.